BARD noninvasive prediction score for advanced fibrosis in nonalcoholic fatty liver

BARD noninvasive prediction score for advanced fibrosis in nonalcoholic fatty liver
[select name="Q1" value="no (0 points)=0|YES (1 point)=1"] <-- BMI: 28 or higher
[select name="Q2" value="no (0 points)=0|YES (2 point)=2"] <-- AST to ALT Ratio (AAR): 0.8 or higher
[select name="Q3" value="no (0 points)=0|YES (1 point)=1"] <-- Type 2 Diabetes Mellitus
score --> [calc memo="number" value="score1=(Q1)+(Q2)+(Q3)"]
interpretation --> [calc memo="result" value="score2=(Q1)+(Q2)+(Q3);score2>1?'Advanced fibrosis is possible, further evaluation may be needed':'Advanced fibrosis is unlikely, negative predictive value of score is 90-97%'"]
[checkbox memo="display/hide references" name="footnotes" value=""][conditional field="footnotes" condition="(footnotes).is('')"]
reference:  
[link url="http://www.ncbi.nlm.nih.gov/pubmed/18390575" memo="#1"] Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008 Oct;57(10):1441-7.
[link url="http://www.ncbi.nlm.nih.gov/pubmed/20584330" memo="#2"] Raszeja-Wyszomirska J, Szymanik B, Ławniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol. 2010 Jun 28;10:67.
[/conditional]